Company
Standard Molecular, Inc.
Also known as Standard Molecular
- Business model
- B2B
Record updated 28 September 2026
About
is transforming patient care and development of personalized therapies through integrated genomic data. The company’s proprietary platform addresses a key pain point in the rapidly growing use of molecular testing by enabling the exchange of standardized, discrete genomic data to streamline information flow between physician practices and molecular labs.